Business
Companies
Inside Twitter’s decision to cut off Trump
Jack Dorsey was working remotely on a private island in French Polynesia when a Twitter executive phoned to reveal the decision to lock down President Trump's account.
- by Kate Conger and Mike Isaac
Latest
Grounded: Qantas stuck on the tarmac in pandemic recovery journey
State border closures and the realisation vaccines won't be a ticket to overseas travel has set back Qantas' long recovery from COVID-19.
- by Patrick Hatch
Shareholders give Kalgoorlie's 'merger of equals' a golden pass
The merger is expected to be completed by mid-February after it gets the green light from the WA Supreme Court.
- by Hamish Hastie
Experts call for calm on Pfizer vaccine supply after pre-order 'guessing game'
Play the long game: Vaccine industry experts say it's understandable that Australia is struggling to secure more Pfizer doses, but the government could not have done much differently.
- by Emma Koehn
'Down the rabbit hole': Trump backers seek online refuges after big tech backlash
Online supporters of President Donald Trump are scattering to smaller social media platforms, fleeing what they say is unfair treatment by Facebook, Twitter and other big tech firms looking to squelch misinformation and threats of violence.
- by David Klepper and Amanda Seitz
Major employers delay return to office until February
As government advice on borders and CBDs chops and changes, some of the country's largest companies are taking a cautious approach to returning to work.
- by Charlotte Grieve
Exclusive
Workplace culture
Senior IOOF executive accused of 'inappropriate' touching in unfair dismissal claim
A former IOOF executive has accused the wealth manager's deputy chief investment officer Stanley Yeo of sexual harassment.
- by Sarah Danckert
Opinion
Coal
Australia's diplomatic divorce with China is getting more expensive
Recent Australian government attempts to seek retribution against China's trade bans and restrictions are looking increasingly like own goals.
- by Elizabeth Knight
ASX market darling Pro Medicus surges on breakthrough US contract
The $3.7 billion medical technology operator is inking big contracts as the pandemic rages in North America.
- by Emma Koehn
Twitter CEO says Trump ban was right, but sets a 'dangerous precedent'
In a lengthy philosophical tweetstorm, Twitter chief executive Jack Dorsey said he took no pride in the decision to remove President Donald Trump's account from the service last week.
- by Elizabeth Dwoskin
CSL leaves door open for Novavax but has hands full with AZ vaccine
Biotechnology giant CSL has dampened speculation it could make the Novavax coronavirus vaccine onshore at the same time as it produces AstraZeneca's product.
- by Emma Koehn